期刊
JOURNAL OF NEPHROLOGY
卷 34, 期 4, 页码 1039-1040出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s40620-021-01091-1
关键词
BioNTech; Pfizer vaccine; COVID-19; Glomerular disease; Minimal change disease; SARS-CoV-2 vaccine